Buyer landscape

Likely buyers · Pharma in Netherlands.

Prepared 2026-08-29 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables

How companies like this sold · 21 verified exits: 24% to sponsors, 57% to corporates and platforms, 14% via IPO, 5% other routes. Route shift since 2020: sponsors 23% (was 30%), corporates and platforms 67% (was 54%), IPO 8% (was 15%) (sector-wide).

The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers, including 10 geographic expansion candidates without a local platform yet. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.

Financial buyers · 25

Tier 1 · Very High · score 70+

1. ARCHIMED and Institut Mérieux SponsorVery High83

54 platform investments in Healthcare · 19 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

2. ArchiMed SponsorVery High82

56 platform investments in Healthcare · 18 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

3. Archimedes Partners SponsorVery High82

53 platform investments in Healthcare · 21 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

4. ArchiMed and Tethys Invest SponsorVery High82

54 platform investments in Healthcare · 18 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

5. SHS Gesellschaft für Beteiligungsmanagement SponsorVery High82

37 platform investments in Healthcare · 4 in Netherlands · 6 deals 2024–26

SHS VI · 2022 vintage · partially deployed · check €5-41M

12 platform investments since the 2022 vintage · largely deployed vs its usual 8 per fund.

Backed AMW, 2026 · Pharma, Germany

6. IK Partners SponsorVery High80

34 platform investments in Healthcare · 22 in Netherlands · 52 deals 2024–26

AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M

18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.

Backed Ceva Santé Animale, 2003 · Pharma, France

7. Bpifrance Investissement SponsorVery High80

10 platform investments in Healthcare · 35 deals 2024–26

AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M

Accelerating: 30 deals in the last 2 years vs 4.5/yr before.

Backed Biogaran, 2026 · Pharma, France

8. BC Partners SponsorVery High78

19 platform investments in Healthcare · 5 in Netherlands · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

9. Inflexion SponsorVery High78

10 platform investments in Healthcare · 2 in Netherlands · 27 deals 2024–26

AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M

4 platform investments since the 2026 vintage · mid-deployment vs its usual 6 per fund.

Bought Primed from Paragon Partners, 2026 · MedTech, Germany

10. Merieux Equity Partners / Vitruvian Partners SponsorVery High78

57 platform investments in Healthcare · 2 in Netherlands · 6 deals 2024–26

AUM €1.6B · Mérieux Participations 5 · 2026 vintage · deploying · check €7-50M

2 platform investments since the 2026 vintage · early in deployment vs its usual 8 per fund.

Backed CEVA Santé Animale, 2025 · Pharma, France

11. BC Partners / PSP Investments / Ontario Teachers SponsorVery High78

13 platform investments in Healthcare · 4 in Netherlands · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

12. BC Partners + Intermediate Capital Group SponsorVery High78

13 platform investments in Healthcare · 4 in Netherlands · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

13. BC Partners and AXA Private Equity SponsorVery High78

14 platform investments in Healthcare · 4 in Netherlands · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

14. BC Partners Fund XI and CPP Investments SponsorVery High78

13 platform investments in Healthcare · 4 in Netherlands · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

15. Armira SponsorVery High78

6 platform investments in Healthcare · 1 in Netherlands · 12 deals 2024–26

AUM €5.0B · Armira III · 2025 vintage · deploying · check €20-150M

8 platform investments since the 2025 vintage · mid-deployment vs its usual 10 per fund.

Backed almapharm, 2024 · Pharma, Germany

16. EQT SponsorVery High77

50 platform investments in Healthcare · 9 in Netherlands · 51 deals 2024–26

AUM €291.0B · EQT X · 2023 vintage · deploying · check €440M-3.3B

53 platform investments since the 2023 vintage · largely deployed vs its usual 11 per fund.

Backed Dechra Pharmaceuticals, 2024 · Pharma, UK

17. Bridgepoint SponsorVery High77

34 platform investments in Healthcare · 8 in Netherlands · 43 deals 2024–26